Form 8-K - Current report:
SEC Accession No. 0000950170-24-014950
Filing Date
2024-02-14
Accepted
2024-02-14 09:00:04
Documents
2
Period of Report
2024-02-13
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evoke_closing_8k_feb_13.htm 8-K 44151
2 EX-4.1 evok-ex4_1.htm EX-4.1 141862
  Complete submission text file 0000950170-24-014950.txt   187221
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 24632762
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)